Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat

@article{Novinscak2007GastricPB,
  title={Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat},
  author={Tomislav Novinscak and Luka Br{\vc}i{\'c} and Mario Stare{\vs}ini{\'c} and Ivana Juki{\'c} and Bo{\vz}o Radi{\'c} and Danira Pevec and Sandro Mise and Sanja Tomasovi{\'c} and Iva Br{\vc}i{\'c} and Tihomir Bani{\'c} and Ana Jakir and Gojko i suradnici Buljat and Tomislav Anic and Ivan Zori{\vc}i{\'c} and Željko Romi{\'c} and Sven Seiwerth and P Sikiri{\'c}},
  journal={Surgery Today},
  year={2007},
  volume={38},
  pages={716-725}
}
Stable gastric pentadecapeptide BPC 157 accelerates the healing of a transected Achilles tendon and a transected quadriceps muscle. It may also be of clinical relevance as a systemic and local peptide treatment for crush injury of a major muscle, such as gastrocnemius muscle complex. BPC 157 is effective without a carrier, and it is presently undergoing trials for inflammatory bowel disease, and no toxicity has so far been reported. In crushed rats (force delivered 0.727 Ns/cm2), BPC 157 was… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 16 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 43 REFERENCES

A multicenter , randomized , double blind , placebo - controlled phase II study of PL 14736 enema in the treatment of mildtomoderate ulcerative colitis

  • M Ruenzi, M Stolte, M Veljaca, K Oreskovic, J Peterson
  • Gastroenterology
  • 2005

Ulcerative Colitis Study Group. A multicenter, randomized, double blind, placebo-controlled phase II study of PL 14736 enema in the treatment of mild-to-moderate ulcerative colitis

  • M Ruenzi, M Stolte, M Veljaca, K Oreskovic, J Peterson
  • Gastroenterology
  • 2005

Similar Papers

Loading similar papers…